002422.SZ Stock Analysis
00
Neutral
Based on Eyestock quantitative analysis, 002422.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Undervalued
Sichuan Kelun Pharmaceutical Co., Ltd. engages in research, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Chengdu, Sichuan and currently employs 19,031 full-time employees. The company went IPO on 2010-06-03. The firm operates its businesses through manufacture and distribution of injections, booster injections, lyophilized power injections, tablets, capsules, granules, oral liquids, dialysis fluids and other form of pharmaceuticals, bulk pharmaceutical chemicals, pharmaceutical packing materials, as well as medical equipment. The firm's injection products include general injections and therapeutic injections, such as glucose injections, sodium chloride injections, glucose and sodium chloride injections, ofloxacin injections, metronidazole injections and norfloxacin injections, among others. Through its subsidiaries, it also engages in the manufacture of rubber and plastic products. The firm distributes its products within domestic market and to overseas markets.